Clinical Trials Browser

Prostatic Neoplasms × cirmtuzumab × Genitourinary × Clear all

NCT05156905 2024-10-09

Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms